Case of Palytoxin-Related Keratitis Described

This article originally appeared here.
Share this content:
Case of Palytoxin-Related Keratitis Described
Case of Palytoxin-Related Keratitis Described

FRIDAY, May 6, 2016 (HealthDay News) -- In a letter to the editor published online April 30 in Clinical and Experimental Ophthalmology, unilateral palytoxin-induced chemical keratitis is described after a coral expressed its toxin into the patient's eye.

Nadia L. Chaudhry, from the Manchester Royal Eye Hospital in the United Kingdom, and colleagues described the case of a 45-year-old Caucasian female coral farmer who presented one day after a coral (Palythoa sp) expressed a toxin directly into her left eye.

On examination, visual acuity in the affected eye was 6/5; eyelid swelling, conjunctival chemosis and injection, diffuse punctate epithelial erosions, and a circumferential marginal ulcer were seen on slit lamp examination. The researchers diagnosed the patient with unilateral chemical keratitis. Topical ofloxacin eye drops were prescribed six times per day, along with hourly preservative-free lubricants. The patient felt subjectively worse the next day and was started on prednisolone eye drops twice/day. The pain decreased three days later, but there was still a 360-degree circumferential marginal infiltrate. Prednisolone eye drops were increased to four times/day. The eye looked white and quiet with mild peripheral corneal scarring and persistent corneal vascularization four weeks later. Over three months the steroids were tapered; the clinical picture remained unchanged.

"This case draws attention to the danger of their toxins and we recommend the use of protective equipment (face mask, goggles, and gloves) whilst handling these coral," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »